Patterns of nodal metastasis and surgical management of the neck in supraglottic laryngeal carcinoma

Abstract

BACKGROUND: Appropriate management of the clinically negative (N0) neck in supraglottic laryngeal cancer continues to be an area of controversy in head and neck surgery. Our treatment policy has been aggressive surgical management even in the clinically N0 neck.

METHODS: Between 1971 and 1991, 104 patients had the primary diagnosis of supraglottic laryngeal cancer. Ninety of these patients received their treatment at Roswell Park Cancer Institute and are the subject of this retrospective review.

RESULTS: All neoplasms included in this study were squamous cell cancers. The most common subsite involved with tumor in our series was the epiglottis, followed by the aryepiglottic folds and false cords. Supraglottic laryngectomy was performed of 29% of the cases; the remainder received total laryngectomy. Thirty-six percent of the patients had pathologic stage I/II disease, and 64% had stage III/IV. The 5-year survival rates were 100%, 81%, 73%, and 63% for stages I through IV, respectively. Fifty-seven patients had clinically N0 disease at presentation; of these 34 underwent elective neck dissection, and the remaining 23 patients were observed. Of those patients receiving neck dissection, 30% (n = 10) were found to have histologically positive disease, and of the 23 patients observed, 30% (n = 7) had histologically positive regional (neck) disease. Of the 17 clinically N0 and pathologically N+ patients, 82% (14 of 17) had involvement of level I (submandibular triangle), and 100% had involvement of level II. The incidence of bilateral disease in the clinically N0 patient was 44%. There were no local failures.

CONCLUSIONS: There is a high incidence of occult regional disease even in early-stage supraglottic squamous cell carcinoma of the larynx. In the surgical management the clinically N0 neck, we presently recommend bilateral neck dissection of levels I through IV to adequately address those regions at highest risk for occult disease. (Otolaryngol Head Neck Surg 1999;121:57-61.)

Get full access to this article

View all access options for this article.

References

1. DeSanto

Cancer of the supraglottic larynx: a review of 260 patients. Otolaryngol Head Neck Surg 1985; 93:705–11.

2. McGavran

Bauer

Ogura

JH.

The incidence of cervical lymph node metastases from epidermoid carcinoma of the larynx and their relationship to certain characteristics of the primary tumor. Cancer 1961; 14:55–66.

3. Spiro

Gallo

Shah

JP.

Selective jugular node dissection in patients with squamous carcinoma of the larynx or pharynx. Am J Surg 1993; 166:399–402.

4. Wenig

Applebaum

EL.

The submandibular triangle in squamous cell carcinoma of the larynx and hypopharynx. Laryngoscope 1991; 101:516–8.

5. Candela

Shah

Jacques

Patterns of cervical node metastasis from squamous cell carcinoma of the larynx. Arch Otolaryngol Head Neck Surg 1990; 116:432–5.

6. Robbins

Medina

Wolfe

Standardizing neck dissection terminology. Arch Otolaryngol Head Neck Surg 1991; 117:601–5.

7. DeSanto

Carlos

O'Fallon

WM.

The “second” side of the neck in supraglottic cancer. Otolaryngol Head Neck Surg 1990; 102:351–61.

8. Pera

Moreno

Galindo

Prognostic factors in laryngeal carcinoma: a multifactorial study of 416 cases. Cancer 1986; 58: 928–34.

9. Gavilán

Gavilán

Five-year results of functional neck dissection for cancer of the larynx. Arch Otolaryngol Head Neck Surg 1989; 115:1193–6.

10.

10. Galioto

Mevio

Benazzo

Prognostic parameters in metastatic spread of laryngeal cancer: clinicohistopathological correlations. Clin Otolaryngol 1987; 12:303–8.

11.

11. Calhoun

Stiernberg

Hokanson

Laryngeal cancer without spread to the neck: treatment options and outcome. South Med J 1988; 81:1369–74.

12.

12. Pietrantoni

Fior

Clinical and surgical problems of cancer of the larynx and hypopharynx. Acta Otolaryngol 1958; 49:149.

13.

13. Clayman

Frank

Selective neck dissection of anatomically appropriate levels is as efficacious as modified radical neck dissection for elective treatment of the clinically negative neck in patients with squamous cell carcinoma of the upper respiratory and digestive tracts. Arch Otolaryngol Head Neck Surg 1998; 124:348–52.

14.

14. DeSanto

Beahrs

Holt

Neck dissection and combined therapy: study of effectiveness. Arch Otolaryngol Head Neck Surg 1985; 111:366–70.

15.

15. Huang

Johnson

Schmidt-Ullrich

Postoperative radiotherapy in head and neck carcinoma with extracapsular lymph node extension and/or positive resection margins: a comparative study. Int J Radiat Oncol Biol Phys 1992; 23:737–42.